EI
BHVN icon

EAM Investors’s Biohaven BHVN Stock Holding History

EAM Investors’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-58,364
Closed -$3.19M – 261
2024
Q1 		$3.19M Sell
58,364
-33,487
-36% -$1.66M 0.5% 112
2023
Q4 		$3.93M Buy
91,851
+4,299
+5% +$134K 0.7% 39
2023
Q3 		$2.28M Sell
87,552
-22,289
-20% -$463K 0.44% 80
2023
Q2 		$2.63M Buy
+109,841
New +$1.89M 0.49% 71

Other funds holding BHVN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

EAM Investors's BHVN Position: Q2 2024 in Review

EAM Investors sold out of Biohaven (BHVN) in Q2 2024, closing a stake of 58,364 shares — an estimated $3.19M sold.

EAM Investors first reported a position in BHVN in Q2 2023 and held it in 4 quarters. The position peaked at $3.93M in Q4 2023. 225 funds tracked by Wall St. Rank hold BHVN as of Q2 2024.

  • EAM Investors reported no remaining Biohaven position as of Q2 2024 after selling out during the quarter.
  • EAM Investors sold 58,364 Biohaven shares in Q2 2024, an estimated $3.19M.
  • EAM Investors first reported a position in Biohaven in Q2 2023 and held it in 4 quarters.
  • EAM Investors's Biohaven position peaked at $3.93M in Q4 2023.
  • 225 funds tracked by Wall St. Rank held Biohaven as of Q2 2024.

Based on EAM Investors's 13F filing for Q2 2024, filed 12 Aug 2024.